Safety Profile Evaluation of an Original Mesenchymal Stromal Cell Secretome-Based Medicinal Product after Intratesticular Injection in Rabbits

INTRODUCTION. This work is a continuation of the studies of an original biological product based on the secretome of human mesenchymal stromal cells (MSCs) and intended for the restoration of spermatogenesis and fertility. To ensure the safety of the product, it is necessary to conduct preclinical studies in two types of animals, including rodents (the results of rodent studies were presented earlier) and non-rodents.

AIM. This study aimed to investigate the systemic toxicity, safety pharmacology, pyrogenicity, immunotoxicity, reproductive toxicity, and local tolerance of the original MSC secretome product in mature rabbits after two injections under the tunica albuginea of the testes.

MATERIALS AND METHODS. The study was conducted in 50 male Soviet chinchilla rabbits (5 groups of 10 animals). The lyophilised MSC secretome product (MediReg) was reconstituted, mixed with collagen gel (Applicoll), and administered to rabbits subalbugineally on days 1 and 28 at a dose equal to the therapeutic dose (≥0.76 ng of vascular endothelial growth factor (VEGF)), 1.5 therapeutic doses (≥1.14 ng of VEGF), or 2.5 therapeutic doses (≥1.9 ng of VEGF). The control groups included intact rabbits and rabbits that received Applicoll mixed with water for injection. The animals were assessed in terms of their clinical condition, body temperature, electrocardiogram changes, heart and respiratory rates, blood pressure, modified Irwin test results, urinalysis findings, blood counts and biochemistry, haemostasis parameters, arterial blood gas measurements, and spermogram changes. Further, the animals were necropsied, and selected organs were weighed and subjected to histopathology. The follow-up period was 60 days.

RESULTS. On day 3, the groups receiving 1.5 and 2.5 therapeutic doses of the medicinal product demonstrated a significant decrease in prothrombin time; however, only the placebo group still had decreased prothrombin time levels during the follow-up period. The histological examination revealed occasional splitting areas in the intertubular connective tissue with the formation of cavities filled with a loose substance with pronounced eosinophilic staining and deformation of the tubules along the walls of the cavities as a result of compression in 1–2 of 5 (20–40%) rabbits in all groups that received either the medicinal product or placebo. This was probably caused by mechanical compression of the tubules by the administration of large volumes of substances. In the placebo group, 2 of 5 (40%) animals had a transient increase in the size of the vesicular glands; the lobules were markedly expanded and contained a transparent secretion. The histological appearance of the vesicular glands was normal.

CONCLUSIONS. When administered twice under the tunica albuginea of the testes of rabbits, the medicinal product comprising the MSC secretome and the Applicoll collagen gel carrier has an acceptable safety profile.

1. Punab M, Poolamets O, Paju P, Vihljajev V, Pomm K, Ladva R, et al. Causes of male infertility: A 9-year prospective monocentre study on 1737 patients with reduced total sperm counts. Hum Reprod. 2017;32(1):18–31. https://doi.org/10.1093/humrep/dew284

2. Jungwirth A, Giwercman A, Tournaye H, Diemer T, Kopa Z, Dohle G, et al. European Association of Urology guidelines on male infertility: The 2012 update. Eur Urol. 2012;62(2):324–32. https://doi.org/10.1016/j.eururo.2012.04.048

3. Sagaradze G, Basalova N, Kirpatovsky V, Ohobotov D, Nimiritsky P, Grigorieva O, et al. A magic kick for regeneration: Role of mesenchymal stromal cell secretome in spermatogonial stem cell niche recovery. Stem Cell Res Ther. 2019;10(1):342. https://doi.org/10.1186/s13287-019-1479-3

4. Caroppo E, Colpi GM. Male infertility: A review of key papers appearing in the reproductive medicine and andrology section of the Journal of Clinical Medicine. J Clin Med. 2023;12(6):2366. https://doi.org/10.3390/jcm12062366

5. Fainberg J, Kashanian JA. Recent advances in understanding and managing male infertility. F1000Res. 2019;8:(F1000 Faculty Rev):670. https://doi.org/10.12688/f1000research.17076.1

6. Chen G, Kathrins M, Ohlander S, Niederberger C. Medical management of male infertility: Now and future. Curr Opin Urol. 2023;33(1):10–5. https://doi.org/10.1097/MOU.0000000000001056

7. Dissanayake DMDH, Keerthirathna WLR, Peiris LDC. Male infertility problem: A contemporary review on present status and future perspective. Gender and the Genome. 2019;3:1–7. https://doi.org/10.1177/2470289719868240

8. Minhas S, Bettocchi C, Boeri L, Capogrosso P, Carvalho J, Cilesiz NC, et al. European Association of Urology Guidelines on male sexual and reproductive health: 2021 update on male infertility. Eur Urol. 2021;80(5):603–20. https://doi.org/10.1016/j.eururo.2021.08.014

9. Kalinina N, Kharlampieva D, Loguinova M, Butenko I, Pobeguts O, Efimenko A, et al. Characterization of secretomes provides evidence for adipose-derived mesenchymal stromal cells subtypes. Stem Cell Res Ther. 2015;6:221. https://doi.org/10.1186/s13287-015-0209-8

10. Fujii S, Miura Y. Immunomodulatory and regenerative effects of MSC-derived extracellular vesicles to treat acute GVHD. Stem Cells. 2022;40(11):977–90. https://doi.org/10.1093/stmcls/sxac057

11. Sagaradze GD, Basalova NA, Kirpatovsky VI, Ohobotov DA, Grigorieva OA, Balabanyan VY, et al. Application of rat cryptorchidism model for the evaluation of mesenchymal stromal cell secretome regenerative potential. Biomed Pharmacother. 2019;109:1428–36. https://doi.org/10.1016/j.biopha.2018.10.174

12. Monakova A, Sagaradze G, Basalova N, Popov V, Balabanyan V, Efimenko A. Novel potency assay for MSC secretome-based treatment of idiopathic male infertility employed Leydig cells and revealed vascular endothelial growth factor as a promising potency marker. Int J Mol Sci. 2022;23(16):9414. https://doi.org/10.3390/ijms23169414

13. Monakova AO, Sagaradze GD, Balabanyan VYu, Basalova NA, Matichinа АА, Matichin АА, et al. Safety study of an original mesenchymal stromal cell secretome-based medicinal product for spermatogenesis restoration. Safety and Risk of Pharmacotherapy. 2023;12(1):99–116 (In Russ.). https://doi.org/10.30895/2312-7821-2023-364

14. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 1968;13(3):222–57. https://doi.org/10.1007/BF00401402

15. Palozi RAC, Guarnier LP, Romão PVM, Nocchi SR, Dos Santos CC, Lourenço ELB, et al. Pharmacological safety of Plinia cauliflora (Mart.) Kausel in rabbits. Toxicol Rep. 2019;6:616–24. https://doi.org/10.1016/j.toxrep.2019.06.017

16. Gushchin YaA, Muzhikyan AA. Effect of fixing liquids on the microscopic structure of organs of small laboratory animals. International Bulletin of Veterinary Science. 2014;(3):88–95 (In Russ.). EDN: SUEDYF

17. Muzhikyan AA, Makarova MN, Guschin YaA. Features histological processing of organs and tissues of laboratory animals. International Bulletin of Veterinary Medicine. 2014;(2):103–9 (In Russ.). EDN: SFLHTJ

18. Melillo A. Rabbit clinical pathology. Journal of Exotic Pet Medicine. 2007;16(3):135–45. https://doi.org/10.1053/j.jepm.2007.06.002